Unspecified neoadjuvant immunochemotherapy regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Unspecified neoadjuvant immunochemotherapy regimen, covering 2024-07-01 to 2024-07-01. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction [Phase 2]